These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36171661)

  • 1. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR
    J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
    Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
    J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime cancer risks in individuals with germline PTEN mutations.
    Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
    Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
    Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
    Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.
    Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF
    Fam Cancer; 2014 Mar; 13(1):57-63. PubMed ID: 23934601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on age-related cancer risks in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Schuurs-Hoeijmakers JHM; Vos JR
    Clin Genet; 2021 Feb; 99(2):219-225. PubMed ID: 33140411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
    Mester JL; Zhou M; Prescott N; Eng C
    Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
    Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications for Germline PTEN Spectrum Disorders.
    Ngeow J; Sesock K; Eng C
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome.
    Sloot YJE; Rabold K; Netea MG; Smit JWA; Hoogerbrugge N; Netea-Maier RT
    Oncogene; 2019 May; 38(19):3743-3755. PubMed ID: 30670777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
    Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
    J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
    Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
    Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.
    Brewer T; Yehia L; Bazeley P; Eng C
    Am J Hum Genet; 2022 Aug; 109(8):1520-1533. PubMed ID: 35931053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
    Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
    PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
    Hoxhaj A; Drissen MMCM; Vos JR; Bult P; Mann RM; Hoogerbrugge N
    Cancer; 2022 Aug; 128(15):2883-2891. PubMed ID: 36533707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of
    Liu A; Borges PM; Tay YS; Thompson LDR; Kong MX; Lai J
    Anticancer Res; 2022 Mar; 42(3):1481-1485. PubMed ID: 35220242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.